BioArctic : Eisai's Leqembi Approved In Israel For Alzheimer's Disease Treatment
12/7 05:24
(RTTNews) - BioArctic AB's partner Eisai announced that Leqembi (generic name: lecanemab) has been approved for treatment of Alzheimer's disease or AD in Israel....